ION CHANNEL INHIBITOR COMPOUNDS FOR CANCER TREATMENT
The present invention concerns a compound of following general formula (I): where: either R is an R1 group and R′ is an -A1-Cy1 group, or R is an -A1-Cy1 group and R′ is an R1 group, R1 particularly being H or (C1-C6)alkyl group;A1 being an —NH— radical or —NH—CH2— radical;Cy1 particularly being a phenyl group,A is a fused (hetero)aromatic ring having 5 to 7 atoms, for use for treating cancer.
-
Paragraph 0261; 0262; 0263; 0316; 0317
(2021/01/25)
METALLOENZYME INHIBITOR COMPOUNDS
Provided are compounds having HDAC6 modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by HDAC6.
-
Page/Page column 182
(2018/09/28)
More Articles about upstream products of 1057246-78-2